CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
NUVISION NAV Ultrasound Catheterdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05970120
NCT05970120N/ACompleted

Clinical Evaluation of Intracardiac Ultrasound With the NUVISION NAV Ultrasound Catheter

Biosense Webster, Inc.·interventional·Posted Aug 1, 2023·Updated May 20, 2025

In Brief

A clinical study evaluating NUVISION NAV Ultrasound Catheter for Scar-related Atrial Tachycardia and 4 related conditions. Completed, enrolled 30 participants across 3 sites in 3 countries.

Detailed Summary

The purpose of this study is to assess the performance and safety of using the investigational catheter.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCroatia, Israel, Italy
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedAug 1, 2023
Enrollment StartSep 5, 2023
Primary CompletionFeb 22, 2024
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 2.9 years ago

Interventions

NUVISION NAV Ultrasound Catheterdevice

Participants will be scheduled to have a clinically-indicated ablation procedure using NUVISION NAV ultrasound catheter for management of atrial procedure.